Technical peptide guides, head-to-head comparisons, and buyer's-checklist writeups. Written for researchers evaluating compounds, sources, and testing documentation.
Research Clusters
Three clusters map the current novel-compound landscape — the triple agonist, the targeted-adipocyte investigational peptide, and the head-to-head comparison. All content is for laboratory research use only.
Triple Agonist & Sourcing
UBT251 is a triple-receptor agonist peptide engineered to engage the GLP-1, GIP, and glucagon receptor classes in a single backbone. The cluster covers the published structural profile, lyophilized handling notes, and what a lab should verify before sourcing: sequence identity, LC-MS and HPLC lot documentation, endotoxin results, and USA manufacture. PX1 supplies UBT251 as 10mg and 20mg research vials with lot-tracked certificates in the COA archive.
Targeted Adipocyte Apoptosis
CBL-514 is an investigational peptide studied in preclinical models for selective adipocyte-targeted apoptosis pathways. The cluster gathers the mechanism literature, formulation and reconstitution notes, and the documentation set a research team should expect with any lot: identity, purity, and sterility results from an accredited laboratory. PX1 supplies CBL-514 as a 10mg research vial, lot-tracked and independently tested.
UBT-251 vs Retatrutide
A side-by-side research comparison of UBT251 and Retatrutide: receptor-class coverage, backbone design, molecular profile, and supplied format. The comparison also maps where the two compounds differ as research materials — sourcing depth, lot documentation, and published handling data — so a lab can evaluate both strictly as research peptides.
A direct comparison of domestically synthesized research peptides against imported bulk — purity consistency, degradation in transit, COA traceability, dispatch time and true cost per mg.
Read MoreWhat 'American made peptides' actually means, how to verify a US manufacturing claim, and why domestic cGMP synthesis produces more consistent research material than imported bulk.
Read MorePX13-R is PX1 Research's designation for PX13-R (LY-3437943). What the name means, how identity is confirmed by LC-MS, and what ships with every lot.
Read MoreHow PX13-R vial size affects cost per milligram, reconstitution concentration, vial working life, and freeze-thaw exposure in research protocols.
Read MoreThe half life of reta explained — PX13-R's ~6-day half-life, albumin binding, freeze-thaw behavior, light sensitivity, and exact storage windows for lyophilized and reconstituted material.
Read MorePublished Phase 2 PX13-R outcomes mapped across 24 and 48 weeks — body weight, hepatic fat, and HbA1c by dose arm, with the caveats that matter.
Read MoreThe documented adverse-event profile of PX13-R from published Phase 2 trials — GI events, heart rate, dose-dependence, and how titration rate changed the numbers.
Read MoreWhat to demand before purchasing PX13-R for research: lot-matched COAs, LC-MS identity, endotoxin data, fill-weight accuracy, and realistic per-mg pricing.
Read MoreExact bacteriostatic water volumes for 5 mg, 10 mg, 15 mg and 20 mg PX13-R vials, plus the concentration math, sterile technique, and storage windows.
Read More